BDX

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Becton, Dickinson And Co.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
CEO
Thomas Polen
Employees
72000
Headquarters

1 Becton Dr
Franklin Lakes, New Jersey 07417-1815
Phone: 12018476800
www.bd.com

News

Top 5 2nd Quarter Trades of PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
Aug 16, 2022 23:00pm

Related Stocks: HON , UNH , PXD , JCI , BDX ,


Source:GuruFocus
Becton Dickinson PT Raised to $319 at Goldman Sachs
Aug 16, 2022 07:45am

https://www.investing.com/news/pro/becton-dickinson-pt-raised-to-319-at-goldman-sachs-432SI-2873259


Source:Investing.com
Top 5 2nd Quarter Trades of STONE RUN CAPITAL, LLC
Aug 15, 2022 23:00pm

Related Stocks: FISV , XRAY , GLW , ROK , BDX ,


Source:GuruFocus
Why Accelerate Diagnostics Shares Are Trading Higher Today
Aug 15, 2022 18:41pm

Becton Dickinson and Co (NYSE: BDX ) will sell Accelerate Diagnostics Inc''s (NASDAQ: AXDX ) rapid testing solution for antibiotic resistance and susceptibility, offering results in hours versus one to two days with some traditional laboratory methods. Becton Dickinson will market and sell the Accelerate Pheno system and Accelerate Arc module and associated test kits through its global sales network. These solutions complement BD''s existing … Full story available on Benzinga.com


Source:Benzinga
Becton, Dickinson to market Accelerate Diagnostics'' rapid tests for antibiotic resistance
Aug 15, 2022 11:26am

Becton, Dickinson and Company (BDX) signed an agreement to offer Accelerate Diagnostics'' (AXDX) rapid testing solution for antibiotic resistance and susceptibility.Under the agreement,…


Source:Seeking Alpha
Embecta Corp. Reports Third Quarter Fiscal 2022 Financial Results
Aug 15, 2022 10:30am

PARSIPPANY, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off from Becton, Dickinson and Company (“BD”), today reported financial results for the three and nine month periods ended June 30, 2022.


Source:GlobeNewswire
Here’s Why ClearBridge Investments Acquired Becton, Dickinson and Company (BDX)
Aug 10, 2022 15:29pm

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” second quarter 2022 investor letter. A copy of the letter can be downloaded here. In the second quarter, the strategy underperformed its Russell 1000 Value benchmark Index. The second quarter was highly volatile due to changes in interest rates, fears of recession, and […]


Source:Insider Monkey
BDXB Crosses Above Key Moving Average Level
Aug 09, 2022 17:00pm

In trading on Tuesday, shares of Becton Dickinson and Company Depositary Shares E (Symbol: BDXB) crossed above their 200 day moving average of $52.02, changing hands as high as $52.16 per share. Becton Dickinson and Company Depositary Shares E shares are currently trading up a


Source:Nasdaq
5 Healthcare Stocks Making Moves After Earnings
Aug 08, 2022 13:02pm

In this article, we discuss the 5 healthcare stocks making moves after earnings. If you want to see some more healthcare companies moving on quarterly results, go directly to 10 Healthcare Stocks Making Moves After Earnings. 5. Becton, Dickinson and Company (NYSE:BDX) Number of Hedge Fund Holders: 49 Shares of Becton, Dickinson and Company (NYSE:BDX) […]


Source:Insider Monkey
Becton, Dickinson and Company – Consensus Indicates Potential 8.2% Upside
Aug 08, 2022 11:29am

Becton, Dickinson and Company found using ticker (BDX) now have 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 290 and 235 calculating the average target price we see 273.18. Given that the stocks previous close was at 252.51 this would indicate that there is a potential upside of 8.2%. The 50 day MA is 245.32 and the 200 moving average now moves to 250.32. The market capitalisation for the company is $72,505m. Find out more information at: https://www.bd.com [stock_market_widget type="chart" template="basic" color="green" assets="BDX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $78,440m based on the market concensus. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.


Source:DirectorsTalk
Global Infusion Pumps and Devices Market Report 2022: Rising Demand for Ambulatory Infusion Pumps, Especially in Home Care Settings Driving Growth - ResearchAndMarkets.com
Aug 08, 2022 09:12am


Source:Kwhen Finance
Becton Dickinson Forecasts Higher Sales From COVID-19 Diagnostic Testing Revenues
Aug 04, 2022 16:16pm

Becton Dickinson and Co (NYSE: BDX ) reported Q3 FY22 revenues of $4.6 billion , up 0.7% Y/Y (3.8% on a currency-neutral basis), better than the consensus of $4.47 billion. Revenue was driven by base revenue growth of 6% as reported, 9.3% currency-neutral. COVID-only testing revenues of $76 million declined from $300 million in the prior year. Medical … Full story available on Benzinga.com


Source:Benzinga
Becton Dickinson and Co (BDX) CEO Thomas Polen on Q3 2022 Results - Earnings Call Transcript
Aug 04, 2022 15:40pm

Becton Dickinson and Co (NYSE:NYSE:BDX) Q3 2022 Earnings Conference Call August 04, 2022, 08:00 ET Company Participants Francesca DeMartino - SVP & Head, IR Thomas Polen - President,…


Source:Seeking Alpha
Becton, Dickinson stock rises after Q3 results beat, raised FY 2022 guidance
Aug 04, 2022 15:28pm

Shares of Becton, Dickinson (BDX), or BD, added as much as 4.7% to $256.41 in Thursday morning trading, after the medical device and health equipment maker reported Q3 results that…


Source:Seeking Alpha
ROUNDUP: Becton, Dickinson And Co. Q3 Profit Down, But Beats Estimates; Ups 2022 Guidance Above View
Aug 04, 2022 11:22am

WASHINGTON (dpa-AFX) - (Adds Outlook)Becton, Dickinson and Company (BDX) reported a profit for third quarter that decreased from last year but beat the Street estimates.The company''s earnings came…


Source:Finanz Nachrichten
Becton Dickinson Tops Q3 EPS by 16c; Raises Outlook By Investing.com
Aug 04, 2022 10:47am

Becton Dickinson Tops Q3 EPS by 16c; Raises Outlook


Source:Investing.com
Becton Dickinson Earnings, Revenue Beat in Q3 By Investing.com
Aug 04, 2022 10:39am

Becton Dickinson Earnings, Revenue Beat in Q3


Source:Investing.com
Becton, Dickinson Non-GAAP EPS of $2.66 beats by $0.16, revenue of $4.64B beats by $170M, raises FY22 guidance
Aug 04, 2022 10:32am

Becton, Dickinson press release (BDX): Q2 Non-GAAP EPS of $2.66 beats by $0.16.Revenue of $4.64B (+0.7% Y/Y) beats by $170M.Revenue from continuing operations driven by base…


Source:Seeking Alpha
Becton, Dickinson and Company: Hold At The Current Valuation
Aug 02, 2022 11:16am

Becton, Dickinson and Company is a dividend aristocrat that will become a dividend king soon. Read more to know why I think BDX stock is a Hold.


Source:Seeking Alpha
Watch this stock’s price performance: Becton Dickinson and Company (NYSE:BDX)
Aug 01, 2022 17:12pm

Becton Dickinson and Company (BDX)’s stock is trading at $244.14 at the moment marking a fall of -0.07% from the last session close. As of this writing, shares are priced at -11.95% less than their 52-week high of $277.29, and 6.50% over their 52-week low of $229.24. Based on the past 30-day period, the stock […]


Source:US Post News
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $8,800 Today
Jul 28, 2022 16:00pm

Becton, Dickinson (NYSE: BDX ) has outperformed the market over the past 20 years by 3.42% on an annualized basis producing an average annual return of 11.36%. Currently, Becton, Dickinson has a market capitalization of $68.64 billion. Buying $1000 In BDX: If … Full story available on Benzinga.com


Source:Benzinga
Becton, Dickinson acquires MedKeeper to offer cloud-based, connected pharmacy software
Jul 28, 2022 11:35am

Becton, Dickinson (BDX) acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications, for providing customers with flexibility and capabilities in meeting…


Source:Seeking Alpha
Becton, Dickinson: Acquisitions Underwhelming (NYSE:BDX)
Jul 27, 2022 22:49pm

We believe the healthcare sector''s strong growth momentum with average revenue growth of 3.8% QoQ suggests a positive outlook with the equipment industry forecasted at a market CAGR of 5.5%.


Source:Seeking Alpha
Becton, Dickinson declares $0.87 dividend
Jul 26, 2022 20:19pm

Becton, Dickinson (BDX) declares $0.87/share quarterly dividend, in line with previous.


Source:Seeking Alpha
Becton, Dickinson and Company – Consensus Indicates Potential 13.3% Upside
Jul 25, 2022 12:15pm

Becton, Dickinson and Company found using ticker (BDX) have now 11 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 290 and 235 calculating the average target price we see 273.18. Now with the previous closing price of 241.08 this indicates there is a potential upside of 13.3%. There is a 50 day moving average of 246.65 and the 200 day moving average is 249.75. The market capitalisation for the company is $69,023m. Find out more information at: https://www.bd.com [stock_market_widget type="chart" template="basic" color="green" assets="BDX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $78,213m based on the market concensus. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.


Source:DirectorsTalk
Becton, Dickinson and Company – Consensus Indicates Potential 17.1% Upside
Jul 18, 2022 11:34am

Becton, Dickinson and Company with ticker code (BDX) have now 11 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 290 and 235 and has a mean target at 274.09. Given that the stocks previous close was at 234.16 this would indicate that there is a potential upside of 17.1%. The 50 day MA is 248.25 while the 200 day moving average is 249.77. The market cap for the company is $68,199m. Company Website: https://www.bd.com [stock_market_widget type="chart" template="basic" color="green" assets="BDX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $79,829m based on the market concensus. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company''s BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems.


Source:DirectorsTalk
Becton, Dickinson and Company (BDX) to Acquire Parata Systems Presentation - Slideshow
Jul 14, 2022 16:28pm

The following slide deck was published by Becton, Dickinson and Company in conjunction with this event.


Source:Seeking Alpha
Peering Into Becton, Dickinson''s Recent Short Interest
Jul 14, 2022 13:18pm

Becton, Dickinson''s (NYSE: BDX ) short percent of float has fallen 31.36% since its last report. The company recently reported that it has 3.31 million shares sold short , which is 1.16% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.9 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com


Source:Benzinga
Now This Analyst Cuts Price Target On Twitter; Here''s The Biggest Price Target Changes For Monday
Jul 11, 2022 11:47am

Baird cut Twitter, Inc. (NYSE: TWTR ) price target from $45 to $33. Twitter shares fell 5.4% to $34.81 in pre-market trading. Raymond James lowered HCA Healthcare, Inc. (NYSE: HCA ) price target from $245 to $220. HCA Healthcare shares fell 1.2% to close at $172.60 on Friday. Citigroup cut the price target on Becton, Dickinson and Company (NYSE: BDX ) from $265 to $235. Becton, Dickinson shares fell 2.4% to $239.62 in pre-market trading. Piper Sandler cut KKR & Co. Inc. (NYSE: Full story available on Benzinga.com


Source:Benzinga
Death Cross Looms Over Becton, Dickinson Investors
Jul 06, 2022 15:00pm

If history is any guide, there may be trouble ahead for shares of Becton, Dickinson (NYSE: BDX ). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions. When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses below the long-term … Full story available on Benzinga.com


Source:Benzinga
embecta Announces Earnings Conference Call Information for the Third Quarter of Fiscal Year 2022
Jul 05, 2022 21:00pm

PARSIPPANY, N.J., July 05, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off from Becton, Dickinson and Company ("BD"), today announced that it will report its financial results for the third quarter of fiscal year 2022 before the market opens on Monday, August 15, 2022.


Source:GlobeNewswire
Global Laboratory Centrifuge Procurement - Sourcing and Intelligence - Exclusive Report by SpendEdge
Jun 30, 2022 13:45pm


Source:Kwhen Finance
BD launches combination test to detect multiple respiratory infections including COVID
Jun 30, 2022 10:42am

Becton, Dickinson (BDX) announced on Thursday that its BD MAX Respiratory Viral Panel ((RVP)) — a combination test designed to detect multiple respiratory infections including COVID-19…


Source:Seeking Alpha
Looking Into Becton, Dickinson''s Recent Short Interest
Jun 28, 2022 13:28pm

Becton, Dickinson''s (NYSE: BDX ) short percent of float has fallen 9.33% since its last report. The company recently reported that it has 3.87 million shares sold short , which is 1.36% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.3 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com


Source:Benzinga
Becton, Dickinson Stock: Advancing Health, Not Performance (NYSE:BDX)
Jun 28, 2022 02:07am

Becton, Dickinson has been underperforming since a massive $24B deal for Bard in 2017. Why am I Neutral BDX stock recent bolt-ons? Click here to find out.


Source:Seeking Alpha
Becton, Dickinson and Company – Consensus Indicates Potential 16.9% Upside
Jun 27, 2022 10:12am

Becton, Dickinson and Company with ticker code (BDX) have now 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 310 and 255 with a mean TP of 283.64. Given that the stocks previous close was at 242.54 this now indicates there is a potential upside of 16.9%. There is a 50 day moving average of 252.19 while the 200 day moving average is 250.27. The company has a market cap of $71,529m. Find out more information at: https://www.bd.com [stock_market_widget type="chart" template="basic" color="green" assets="BDX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $83,649m based on the market concensus. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company''s BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems.


Source:DirectorsTalk
Benzinga''s Top Ratings Upgrades, Downgrades For June 24, 2022
Jun 24, 2022 15:17pm

Upgrades Keefe, Bruyette & Woods upgraded the previous rating for Progressive Corp (NYSE: PGR ) from Underperform to Market Perform. For the first quarter, Progressive had an EPS of $1.11, compared to year-ago quarter EPS of $1.73. The current stock performance of Progressive shows a 52-week-high of $121.36 and a 52-week-low of $89.35. Moreover, at the end of the last trading period, the closing price was at $109.75. According to Noble Capital Markets, the prior rating for Indonesia Energy Corp Ltd (AMEX: INDO ) was changed from Market Perform to Outperform. NoneAt the moment, the stock has a 52-week-high of $86.99 and a 52-week-low of $2.61. Indonesia Energy Corp closed at $6.85 at the end of the last trading period. For Middlesex Water Co (NASDAQ: MSEX ), Janney Montgomery Scott upgraded the previous rating of Neutral to Buy. In the first quarter, Middlesex Water showed an EPS of $0.68, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $121.42 and a 52-week-low of $75.77.


Source:Benzinga
BDX stock higher as Wells Fargo upgrades citing defensive qualities (NYSE:BDX)
Jun 24, 2022 11:49am

The shares of Becton, Dickinson (BDX) are trading higher in the pre-market Friday on low volume after Wells Fargo upgraded the health equipment maker to Overweight from Equal…


Source:Seeking Alpha
Becton, Dickinson and Co voluntarily recalls some intraosseous products
Jun 22, 2022 20:40pm

Becton, Dickinson and Company (BDX) on Wednesday said it was voluntarily recalling some of its intraosseous products due to some issues


Source:Seeking Alpha